Monte Rosa Therapeutics: Q2 Earnings Snapshot

August 11, 2022 GMT

BOSTON (AP) _ Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $26.5 million in its second quarter.

The Boston-based company said it had a loss of 57 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GLUE at